Health Protection and the Center for Digestive Medicine in Glæsibær are collaborating in the field of prevention of colon cancer in individuals.
The goal of this collaboration is to work diligently to educate individuals on colon cancer and encourage those in defined risk groups for screening according to clinical guidelines of the Medical Director of Health. Thus, a systematic effort will be made to reduce the number of deaths and affect the incidence of colon cancer in Iceland, improve the quality of life of individuals and promote savings in the treatment of such injuries.
The importance of reducing cancer-related deaths is clear to everyone. Colon and rectal cancers are today a cause of great health damage and are the second most common cause of cancer deaths among Icelanders. Large studies in which individuals have been followed for close to two decades have shown that deaths from these cancers can be reduced by screening for stools or colonoscopy.
Screening has already begun in many countries around us, but colon cancer meets all the conditions justified for it, the main ones being the following;
- It is a disease that is common and causes great health problems or deaths.
- Screening methods can diagnose the disease on medical precursors, are acceptable to the patient and easier to implement.
- The treatment that is diagnosed after screening has been shown to be more effective than without screening
- The benefits of screening outweigh the potential damage and its cost
Health protection has through its general education and web site www.doktor.is contributed to the vigilance of the disease, but also through targeted health screenings and risk assessment of individuals.
The Center for Digestive Medicine will undertake colonoscopy of individuals who undergo clinical trials according to clinical guidelines. In addition, their physicians will direct treatment and follow-up of patients who may be diagnosed, in collaboration with a competent body.
For more information, call 510-6500 or email email@example.com